Cholesterol

Cholesterol

SCHEMBL162526

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.O=C(O)c1ccccc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Cholesterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 1/20 0.65
OSBP P22059 4/20 0.82
RORC P51449 3/20 0.82
OSBP2 Q969R2 2/20 0.82
USP2 O75604 1/20 0.82
LMNA P02545 1/20 0.82
ABCB1 P08183 1/20 0.82
CYP46A1 Q9Y6A2 1/20 0.82
NR1H3 Q13133 7/20 0.71
EPHA2 P29317 1/20 0.71
GRIN1 Q05586 2/20 0.70
GRIN2A Q12879 2/20 0.70
NPC1L1 Q9UHC9 3/20 0.67
CRYAB P02511 1/20 0.67
HMGCR P04035 1/20 0.67
ITGB3 P05106 1/20 0.67
ITGAV P06756 1/20 0.67
SREBF2 Q12772 1/20 0.67
POLA1 P09884 1/20 0.66
GRIN2B Q13224 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cholesterol SCHEMBL29065777 1.00 OSBP (0.82) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL28035647 1.00 OSBP (0.82) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL1296896 0.93 OSBP (0.82) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL29033213 0.93 OSBP (0.82) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL27608874 0.93 OSBP (0.91) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL27668883 0.92 OSBP (0.93) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL1369602 0.92 OSBP (0.93) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL29502101 0.92 OSBP (0.93) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL27942138 0.92 OSBP (0.96) OSBPRORCOSBP2USP2LMNA
Benzoic Acid SCHEMBL11147682 0.92 OSBP (0.68) OSBPRORCOSBP2USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852914-B Thermochromic water-based ink containing cholesterol liquid crystal microcapsules and preparation method 江苏泰格油墨有限公司 2025-06-24 CN claimed
CN-119044072-A Liquid crystal sensor for detecting formaldehyde gas and preparation method thereof 江南大学 2024-11-29 CN claimed
CN-118852914-A Thermochromic water-based ink containing cholesterol liquid crystal microcapsules and preparation method 江苏泰格油墨有限公司 2024-10-29 CN claimed
CN-117599728-A Reaction kettle for vitamin production and production process 新拓洋生物工程有限公司 2024-02-27 CN claimed
CN-117597118-A Pharmaceutical composition for preventing or treating viral infection comprising as active ingredient a crude drug QVET公司 2024-02-23 CN claimed
CN-115851087-B Blue light diffusion prevention coating and application thereof 广东粤港澳大湾区黄埔材料研究院 2023-10-10 CN claimed
CN-114908575-B Liquid crystal ultraviolet-resistant finishing agent and application thereof to textiles 江南大学 2023-06-16 CN claimed
CN-116206540-A Multi-mode display layer made of up-conversion liquid crystal microcapsules and display application 苏州科技大学 2023-06-02 CN claimed
CN-116157171-A Medical device for visually indicating injection pressure of fluid 贝朗梅尔松根股份公司 2023-05-23 CN claimed
CN-112323162-B High-efficiency slow-release microcapsule cellulose fiber for wormwood 广东欣和艾草科技有限公司 2023-05-05 CN claimed
EP-1647259-A1 use for treatment of keratinic materials of compositions comprising electrophilic monomers and agents forming liquid crystals L'OREAL (FR) 2006-04-19 EP claimed
CN-1686156-A Clamycin structurization emulsion composition ZHANG WENFANG (CN) 2005-10-26 CN claimed
US-20050112207-A1 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells SHORR ROBERT (US) 2005-05-26 US claimed
US-6328910-B1 FOR IN SITU FORMATION OF AN POLYMERIC CYANOACRYLATE FILM ON MAMMALIAN SKIN WHICH CAN BE USED TO MONITOR THE SURFACE SKIN TEMPERATURE OF MAMMAL MEDLOGIC GLOBAL CORPORATION 2001-12-11 US claimed
WO-1997027360-A1 PHASE SEPARATION APPARATUS SCAPA GROUP PLC (GB) 1997-07-31 WO claimed
EP-0467031-B1 Medical-grade lipid-coated microbubbles, paramagnetic labelling thereof and their therapeutic use CAVITATION CONTROL TECHNOLOGY (US) 1997-07-30 EP claimed
US-5215680-A Sterilization by filtering through polysulfone membrane the concentrated gas-in-liquid emulsion obtained from dissolving hydrophobic polypeptide-metal organic chelating ligand in fatty acid surfactant and shaking CAVITATION-CONTROL TECHNOLOGY, INC. (US) 1993-06-01 US claimed
EP-0467031-A2 Medical-grade lipid-coated microbubbles, paramagnetic labelling thereof and their therapeutic use CAVITATION-CONTROL TECHNOLOGY, INC. (US) 1992-01-22 EP claimed
CN-1035145-A FLUID CRYSTAL PRINTING WITH POLYURETHANL METHOD WUHAN INST OF TEXTILE SCIENCE (CN) 1989-08-30 CN claimed
US-4684479-A Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures CAVITATION-CONTROL TECHNOLOGY, INC. 1987-08-04 US claimed